Have a personal or library account? Click to login
Antinuclear Antibodies in Non-Rheumatic Diseases Cover

References

  1. Abdullah AM, Sadiqul I, Mamunur R et al. (2006) Coexistence of systemic lupus erythematosus and Addison's disease. Pak J Med Sci Quarterly 22(1). https://pjms.com.pk/issues/janmar06/article/casereport1.html
  2. Abraham S, Begum S, Isenberg D (2004) Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63:123–129. https://doi.org/10.1136/ard.2002.001826
  3. Aghdashi MA, Khadir M, Dinparasti-Saleh R (2020) Antinuclear antibodies and lupus-like manifestations in rheumatoid arthritis and ankylosing spondylitis patients at 4 months' follow-up after treatment with infliximab and etanercept. Curr Rheumatol Rev 16:61–66. https://doi.org/10.2174/1573397115666190506152729
  4. Agmon-Levin N, Damoiseaux J, Kallenberg C et al. (2014) International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 73:17–23. https://doi.org/10.1136/annrheumdis-2013-203863
  5. Almeida RM, Silva ZDL, Leite FB et al. (2019) Antinuclear antibody patterns in patients with celiac disease. Biomed J Sci Tech Res 13. https://biomedres.us/fulltexts/BJSTR.MS.ID.002418.php
  6. Alsaed OS, Alamlih LI, Al-Radideh O et al. (2021) Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases. Sci Rep 11:8229. https://doi.org/10.1038/s41598-021-87366-w
  7. Altintas A, Cil T, Pasa S et al. (2008) Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience. Minerva Medica 99(1):7–14. PMID: 18299692
  8. American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. (2002) Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. Arthritis Care Res 47:429–433. https://doi.org/10.1002/art.10381
  9. Antonelli A, Ferrari SM, Corrado A et al. (2015) Autoimmune thyroid disorders. Autoimmun Rev 14:174–180. https://doi.org/10.1016/j.autrev.2014.10.016
  10. Assassi S, Fritzler MJ, Arnett FC et al. (2009) Primary Biliary Cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 36:2250–2256. https://doi.org/10.3899/jrheum.090340
  11. Astudillo L, Sailler L, Carreiro M et al. (2003) Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems. Annales de Médecine Interne (Paris) 154(1):3–6. French. PMID: 12746653
  12. Austin PM, Thompson HT, Brown AR (2012) Performance of the BMD FIDIS™ Connective 10® ENA luminex method in external quality assurance proficiency programmes in a diagnostic laboratory setting. New Zealand Journal of Medical Laboratory Science 66:8–13. https://www.researchgate.net/publication/287499065_Performance_of_the_BMD_FIDIS_Connective_10R_ENA_luminex_method_in_external_quality_assurance_profi_ciency_programmes_in_a_diagnostic_laboratory_setting
  13. Avaniss-Aghajani E, Berzon S, Sarkissian A (2007) Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens. Clin Vaccine Immunol 14:505–509. https://doi.org/10.1128/CVI.00034-07
  14. Aydin S (2015) A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides 72:4–15. https://doi.org/10.1016/j.peptides.2015.04.012
  15. Barahona-Garrido J, Camacho-Escobedo J, García-Martínez CI et al. (2009) Antinuclear antibodies: a marker associated with steroid dependence in patients with ulcerative colitis. Inflamm Bowel Dis 15:1039–1043. https://doi.org/10.1002/ibd.20852
  16. Beigel F, Schnitzler F, Paul Laubender R et al. (2011) Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease. Inflamm Bowel Dis 17:91–98. https://doi.org/10.1002/ibd.21362
  17. Betterle C, Presotto F, Furmaniak J (2019) Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults. J Endocrinol Invest 42:1407–1433. https://doi.org/10.1007/s40618-019-01079-6
  18. Blondin DA, Zhang Z, Shideler KK et al. (2009) Prevalence of non-organ-specific autoantibodies in patients with pemphigus vulgaris. J Cutan Med Surg 13:82–87. https://doi.org/10.2310/7750.2008.08001
  19. Bonilla E, Francis L, Allam F et al. (2007) Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients. Clin Immunol 124:18–21. https://doi.org/10.1016/j.clim.2007.04.010
  20. Bossuyt X, De Langhe E, Borghi MO et al. (2020) Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases. Nat Rev Rheumatol 16:715–726. https://doi.org/10.1038/s41584-020-00522-w
  21. Butler TAJ, Paul JW, Chan EC et al. (2019) Misleading Westerns: common quantification mistakes in Western blot densitometry and proposed corrective measures. Biomed Res Int 2019:5214821. https://doi.org/10.1155/2019/5214821
  22. Buzzetti R, Zampetti S, Maddaloni E (2017) Adult-onset autoimmune diabetes: current knowledge and implications for management. Nat Rev Endocrinol 13:674–686. https://doi.org/10.1038/nrendo.2017.99
  23. Carrizosa AM, Elorza FL, Camacho FM (1997) Antinuclear antibodies in patients with lichen planus. Exp Dermatol 6:54–56. https://doi.org/10.1111/j.1600-0625.1997.tb00146.x
  24. Carroccio A, D'Alcamo A, Cavataio F et al. (2015) High proportions of people with nonceliac wheat sensitivity have autoimmune disease or antinuclear antibodies. Gastroenterology 149:596–603.e1. https://doi.org/10.1053/j.gastro.2015.05.040
  25. Cassani F, Cataleta M, Valentini P et al. (1997) Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 26:561–566. https://doi.org/10.1002/hep.510260305
  26. Chakravarty EF, Bush TM, Manzi S et al. (2007) Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 56:2092–2094. https://doi.org/10.1002/art.22641
  27. Choi H-W, Kwon YJ, Park J-H et al. (2020) Evaluation of a fully automated antinuclear antibody indirect immunofluorescence assay in routine use. Front Immunol 11:607541. https://doi.org/10.3389/fimmu.2020.607541
  28. Colapietro F, Lleo A, Generali E (2021) Antimitochondrial antibodies: from bench to bedside. Clin Rev Allergy Immunol 63:166–177. https://doi.org/10.1007/s12016-021-08904-y
  29. Courvalin JC, Lassoued K, Bartnik E et al. (1990) The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest 86:279–285. https://doi.org/10.1172/JCI114696
  30. Da Costa GM, Forga Llenas L, Martínez Bruna MS et al. (1992) Adrenal hemorrhage linked to systemic lupus erythematosus associated with the antiphospholipid syndrome. Rev Clín Esp 191:54–5. Spanish. PMID: 1631369
  31. Damoiseaux J, von Mühlen CA, Garcia-De La Torre I et al. (2016) International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Autoimmunity Highlights 7(1):1. https://doi.org/10.1007/s13317-016-0075-0
  32. Damoiseaux J, Boesten K, Giesen J et al. (2005) Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann NY Acad Sci 1050:340–347. https://doi.org/10.1196/annals.1313.036
  33. Damoiseaux J, von Mühlen CA, Garcia-De La Torre I et al. (2016) International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights 7:1. https://doi.org/10.1007/s13317-016-0075-0
  34. Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345:340–350. https://doi.org/10.1056/NEJM200108023450506
  35. de Castro GLC, da Silva Graça Amoras E, Araújo MS et al. (2022) High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection. Eur J Med Res 27:180. https://doi.org/10.1186/s40001-022-00809-6
  36. Deng X, Peters B, Ettore MW et al. (2016) Utility of antinuclear antibody screening by various methods in a clinical laboratory patient cohort. J Appl Lab Med 1:36–46. https://doi.org/10.1373/jalm.2016.020172
  37. Didier K, Bolko L, Giusti D et al. (2018) Autoantibodies associated with connective tissue diseases: what meaning for clinicians? Front Immunol 9:541. https://doi.org/10.3389/fimmu.2018.00541
  38. Dunn W, Shah VH (2016) Pathogenesis of alcoholic liver disease. Clin Liver Dis 20:445–456. https://doi.org/10.1016/j.cld.2016.02.004
  39. Favoino E, Grapsi E, Barbuti G et al. (2023) Systemic sclerosis and primary biliary cholangitis share an antibody population with identical specificity. Clin Exp Immunol 212:32–38. https://doi.org/10.1093/cei/uxad012
  40. Fernandez SA, Lobo AZ, Oliveira ZN et al. (2003) Prevalence of antinuclear autoantibodies in the serum of normal blood dornors. Rev Hosp Clín Fac Med Sao Paulo 58:315–319. https://doi.org/10.1590/S0041-87812003000600005
  41. Fritzler MJ, Behmanesh F, Fritzler ML (2006) Analysis of human sera that are polyreactive in an addressable laser bead immunoassay. Clin Immunol 120:349–356. https://doi.org/10.1016/j.clim.2006.03.007
  42. García MJ, Rodríguez-Duque JC, Pascual M et al. (2022) Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy. Therap Adv Gastroenterol 15:17562848221077837. https://doi.org/10.1177/17562848221077837
  43. Ge Q, Gu X, Yu W et al. (2022) Antinuclear antibodies in healthy population: positive association with abnormal tissue metabolism, inflammation and immune dysfunction. Int Immunopharmacol 113:109292. https://doi.org/10.1016/j.intimp.2022.109292
  44. Giannouli E, Chatzidimitriou D, Gerou S et al. (2013) Frequency and specificity of antibodies against nuclear and cytoplasmic antigens in healthy individuals by classic and new methods. Clin Rheumatol 32:1541–1546. https://doi.org/10.1007/s10067-013-2284-5
  45. Giavedoni LD (2005) Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using Luminex technology. J Immunol Methods 301:89–101. https://doi.org/10.1016/j.jim.2005.03.015
  46. Gilburd B, Abu-Shakra M, Shoenfeld Y et al. (2004) Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation—a homogeneous, multiplexed system. Clin Dev Immunol 11:53–56. https://doi.org/10.1080/10446670410001670490
  47. Gilda JE, Ghosh R, Cheah JX et al. (2015) Western blotting inaccuracies with unverified antibodies: need for a Western Blotting Minimal Reporting Standard (WBMRS). PLoS One 10:e0135392. https://doi.org/10.1371/journal.pone.0135392
  48. Gillespie KM (2006) Type 1 diabetes: pathogenesis and prevention. CMAJ 175:165–170. https://doi.org/10.1503/cmaj.060244
  49. Godswill OC, Odigie OO (2014) Primary adrenal insufficiency (Addison's disease) associated with systemic lupus erythematosus: a rare occurrence. International Journal of Preventive Medicine 5(10):1324–7. PMID: 25400892; PMCID: PMC4223953.
  50. Golberg O, Osborne JE, Hutchinson PE (2011) Antinuclear antibodies associate with loss of response to antitumour necrosis factor-α therapy in psoriasis but do not necessarily predict treatment failure. Br J Dermatol 164:459–460. https://doi.org/10.1111/j.1365-2133.2010.10101.x
  51. Granito A, Yang WH, Muratori L et al. (2010) PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am J Gastroenterol 105:125–131. https://doi.org/10.1038/ajg.2009.596
  52. Grygiel-Górniak B, Rogacka N, Puszczewicz M (2018) Antinuclear antibodies in healthy people and non-rheumatic diseases—diagnostic and clinical implications. Reumatologia 56:243–248. https://doi.org/10.5114/reum.2018.77976
  53. Grygiel-Górniak B, Skoczek W (2023) Molecular background and clinical implications of glucose disorders in patients with psoriatic arthritis. J Clin Med 12:5814. https://doi.org/10.3390/jcm12185814
  54. Guyomard S, Salles G, Coudurier M et al. (2003) Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphoma. Br J Haematol 123:90–99. https://doi.org/10.1046/j.1365-2141.2003.04587.x
  55. Hanly JG, Su L, Farewell V et al. (2010) Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Methods 358:75–80. https://doi.org/10.1016/j.jim.2010.04.005
  56. Heras P, Mantzioros M, Mendrinos D et al. (2010) Autoantibodies in type 1 diabetes. Diabetes Res Clin Pract 90:e40–e42. https://doi.org/10.1016/j.diabres.2010.08.015
  57. Hsieh M-Y, Dai CY, Lee LP et al. (2007) Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C. J Clin Pathol 61:333–337. https://doi.org/10.1136/jcp.2006.046276
  58. Infantino M, Meacci F, Grossi V et al. (2017) The burden of the variability introduced by the HEp-2 assay kit and the CAD system in ANA indirect immunofluorescence test. Immunol Res 65:345–354. https://doi.org/10.1007/s12026-016-8845-3
  59. Ingold CJ, Sathe NC, Khan MAB (2024) Pemphigus vulgaris. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL.
  60. Invernizzi P, Selmi C, Ranftler C et al. (2005) Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25:298–310. https://doi.org/10.1055/s-2005-916321
  61. Jaskowski TD, Schroder C, Martins TB et al. (1996) Screening for antinuclear antibodies by enzyme immunoassay. Am J Clin Pathol 105:468–473. https://doi.org/10.1093/ajcp/105.4.468
  62. Kasperkiewicz M, Ellebrecht CT, Takahashi H et al. (2017) Pemphigus. Nat Rev Dis Primers 3:17026. https://doi.org/10.1038/nrdp.2017.26
  63. Kątnik-Prastowska I (2009) Immunochemia w biologii medycznej. PWN, Warszawa. ISBN: 9788301158125.
  64. Kennedy NA, Heap GA, Green HD et al. (2019) Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol 4:341–353. https://doi.org/10.1016/S2468-1253(19)30012-3
  65. Koch A, Mizrahi V (2018) Mycobacterium tuberculosis. Trends Microbiol 26:555–556. https://doi.org/10.1016/j.tim.2018.02.012
  66. Kohl TO, Ascoli CA (2017) Direct competitive enzyme-linked immunosorbent assay (ELISA). Cold Spring Harb Protoc 2017:db.rot093740. https://doi.org/10.1101/pdb.prot093740
  67. Konstantinou GN (2017) Enzyme-linked immunosorbent assay (ELISA). Methods Mol Biol 1592:79–94. https://doi.org/10.1007/978-1-4939-6925-8_7
  68. Kridin K, Laufer-Britva R, Kridin M et al. (2019) The relationship between pemphigus and systemic lupus erythematosus: a cross-sectional study, systematic review, and meta-analysis. Immunol Res 67:116–122. https://doi.org/10.1007/s12026-019-9065-4
  69. Kroon C, Breuer L, Jones L et al. (2022) Blind spots on western blots: assessment of common problems in western blot figures and methods reporting with recommendations to improve them. PLoS Biol 9:e3001783. https://doi.org/10.1371/journal.pbio.3001783
  70. Kumar V (2007) Pernicious anemia. Medical Laboratory Observer 39(2):28, 30–1. PMID: 17375844
  71. Kumar Y, Bhatia A, Minz R (2009) Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol 4:1. https://doi.org/10.1186/1746-1596-4-1
  72. Küppers R, Schmitz R, Distler V et al. (2005) Pathogenesis of Hodgkin's lymphoma. Eur J Haematol Suppl 66:26–33. https://doi.org/10.1111/j.1600-0609.2005.00451.x
  73. Kurki P, Gripenberg M, Teppo AM et al. (1984) Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease. Liver 4:134–138. https://doi.org/10.1111/j.1600-0676.1984.tb00918.x
  74. Lallier SW, Hill CL, Nichols DP et al. (2019) Protein abundance determination: an optimized Western blot workflow. Ann Clin Lab Sci 49:507–512. PMID: 31471341.
  75. Lanzolla G, Puccinelli L, Giudetti M et al. (2023) Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy. J Endocrinol Invest 46:337–344. https://doi.org/10.1007/s40618-022-01906-3
  76. Laskin CA, Vidins E, Blendis LM et al. (1990) Autoantibodies in alcoholic liver disease. Am J Med 89:129–133. https://doi.org/10.1016/0002-9343(90)90288-O
  77. Leuschner U (2003) Primary biliary cirrhosis—presentation and diagnosis. Clin Liver Dis 7:741–758. https://doi.org/10.1016/S1089-3261(03)00101-6
  78. Li X, Liu X, Cui J et al. (2019) Epidemiological survey of antinuclear antibodies in healthy population and analysis of clinical characteristics of positive population. J Clin Lab Anal 33:e22965. https://doi.org/10.1002/jcla.22965
  79. Lian M, Hua J, Sheng L et al. (2013) Prevalence and significance of autoantibodies in patients with alcoholic liver disease. J Dig Dis 14:396–401. https://doi.org/10.1111/1751-2980.12057
  80. Liberal R, Grant CR, Sakkas L et al. (2013) Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis. Clin Res Hepatol Gastroenterol 37:572–585. https://doi.org/10.1016/j.clinre.2013.04.005
  81. Lleo A, Invernizzi P, Gao B et al. (2010) Definition of human autoimmunity—autoantibodies versus autoimmune disease. Autoimmun Rev 9:A259–A266. https://doi.org/10.1016/j.autrev.2009.12.002
  82. López Casado MÁ, Lorite P, Ponce de León C et al. (2018) Celiac disease autoimmunity. Arch Immunol Ther Exp 66:423–430. https://doi.org/10.1007/s00005-018-0520-z
  83. Lundgren MC, Sapkota S, Peterson DJ et al. (2021) The antinuclear antibody dense fine speckled pattern and possible clinical associations: an indication of a proinflammatory microenvironment. J Immunol Methods 488:112904. https://doi.org/10.1016/j.jim.2020.112904
  84. Marin GG, Cardiel MH, Cornejo H et al. (2009) Prevalence of antinuclear antibodies in 3 groups of healthy individuals. J Clin Rheumatol 15:325–329. https://doi.org/10.1097/RHU.0b013e3181bb971b
  85. McSorley HJ, Maizels RM (2012) Helminth infections and host immune regulation. Clin Microbiol Rev 25:585–608. https://doi.org/10.1128/CMR.05040-11
  86. Meroni PL, Schur PH (2010) ANA screening: an old test with new recommendations. Ann Rheum Dis 69:1420–1422. https://doi.org/10.1136/ard.2009.127100
  87. Montes CL, Acosta-Rodríguez EV, Merino MC et al. (2007) Polyclonal B cell activation in infections: infectious agents' devilry or defense mechanism of the host? J Leukoc Biol 82:1027–1032. https://doi.org/10.1189/jlb.0407214
  88. Morawiec-Szymonik E, Foltyn W, Marek B et al. (2019) Pernicious anemia and the presence of antibodies involved in the development of this disease and other autoimmune diseases. Pol Arch Intern Med 130:31–37. https://doi.org/10.20452/pamw.15094
  89. Muratori P, Muratori L, Verucchi G et al. (2003) Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis 37:1320–1326. https://doi.org/10.1086/379018
  90. Murdjeva MA, Ryasheva NP, Draganov MM et al. (2011) A comparative study of immunological methods for determination of serum antinuclear antibodies. Folia Med 53:21–27. https://doi.org/10.2478/v10153-011-0063-0
  91. Mutapi F, Imai N, Nausch N et al. (2011) Schistosome infection intensity is inversely related to auto-reactive antibody levels. PLoS One 6:e19149. https://doi.org/10.1371/journal.pone.0019149
  92. Naides SJ, Genzen JR, Abel G et al. (2020) Antinuclear antibodies testing method variability: a survey of participants in the College of American Pathologists' proficiency testing program. J Rheumatol 47:1768–1773. https://doi.org/10.3899/jrheum.190933
  93. Nisihara RM, de Bem RS, Hausberger R et al. (2003) Prevalence of autoantibodies in patients with endemic pemphigus foliaceus (fogo selvagem). Arch Dermatol Res 295:133–137. https://doi.org/10.1007/s00403-003-0412-9
  94. Nogai H, Dörken B, Lenz G (2011) Pathogenesis of non-Hodgkin's lymphoma. J Clin Oncol 29:1803–1811. https://doi.org/10.1200/JCO.2010.33.3252
  95. Notsu K, Note S, Nabeya N et al. (1983) Antinuclear antibodies in childhood diabetics. Endocrinol Jpn 30:469–473. https://doi.org/10.1507/endocrj1954.30.469
  96. Op De Beéck K, Vermeersch P, Verschueren P et al. (2012) Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev 12:137–143. https://doi.org/10.1016/j.autrev.2012.02.013
  97. Ozaki S, Ichiyama S, Ito M et al. (2022) Real-world blood examination screening data before initiation of biologics for psoriasis patients. J Dermatol 49:534–538. https://doi.org/10.1111/1346-8138.16333
  98. Pashnina IA, Krivolapova IM, Fedotkina TV et al. (2021) Antinuclear autoantibodies in health: autoimmunity is not a synonym of autoimmune disease. Antibodies 10:9. https://doi.org/10.3390/antib10010009
  99. Patrikiou E, Liaskos C, Mavropoulos A et al. (2020) Autoantibodies against specific nuclear antigens are present in psoriatic disease and are diminished by secukinumab. Clin Chim Acta 510: 400–407. https://doi.org/10.1016/j.cca.2020.07.037
  100. Peng X, Tang J, Wu Y et al. (2014) Novel method for ANA quantitation using IIF imaging system. J Immunol Methods 404:52–58. https://doi.org/10.1016/j.jim.2013.12.004
  101. Peng YC, Hsieh SC, Yang DY et al. (2001) Expression and clinical significance of antinuclear antibody in hepatitis C virus infection. J Clin Gastroenterol 33:402–406. https://doi.org/10.1097/00004836-200111000-00012
  102. Pham BN, Albarede S, Guyard A et al. (2005) Impact of external quality assessment on antinuclear antibody detection performance. Lupus 14:113–119. https://doi.org/10.1191/0961203305lu2069oa
  103. Pillai-Kastoori L, Schutz-Geschwender AR, Harford JA (2020) A systematic approach to quantitative Western blot analysis. Anal Biochem 593:113608. https://doi.org/10.1016/j.ab.2020.113608
  104. Pisetsky DS (2011) Antinuclear antibodies in healthy people: the tip of autoimmunity's iceberg? Arthritis Res Ther 13:109. https://doi.org/10.1186/ar3282
  105. Racoubian E, Zubaid RM, Shareef MA et al. (2016) Prevalence of antinuclear antibodies in healthy Lebanese subjects, 2008–2015: a cross-sectional study involving 10,814 subjects. Rheumatol Int 36:1231–1236. https://doi.org/10.1007/s00296-016-3533-0
  106. Ragusa F, Fallahi P, Elia G et al. (2019) Hashimotos' thyroiditis: epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab 33:101367. https://doi.org/10.1016/j.beem.2019.101367
  107. Rambhia KD, Kharkar V, Pradhan V et al. (2018) A study of prevalence of autoantibodies in patients with lichen planus from Mumbai, India. Indian J Dermatol Venereol Leprol 84:667–671. https://doi.org/10.4103/ijdvl.IJDVL_182_17
  108. Ramirez De Oleo IE, Mejia Saldarriaga M, Silverman M et al. (2017) Polyglandular autoimmune syndrome type IIIB: hyperthyroidism and pernicious anemia, a reminder of the past. J Endocrinol Metab 7:159–161. https://doi.org/10.14740/jem451w
  109. Rendon A, Schäkel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20:1475. https://doi.org/10.3390/ijms20061475
  110. Ricchiuti V, Adams J, Hardy DJ et al. (2018) Automated processing and evaluation of anti-nuclear antibody indirect immunofluorescence testing. Front Immunol 9:927. https://doi.org/10.3389/fimmu.2018.0092
  111. Rigamonti C, Bogdanos DP, Mytilinaiou MG et al. (2011) Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol 2011:976427. https://doi.org/10.1155/2011/976427
  112. Rigon A, Buzzulini F, Soda P et al. (2011) Novel opportunities in automated classification of antinuclear antibodies on hep-2 cells. Autoimmun Rev 10:647–652. https://doi.org/10.1016/j.autrev.2011.04.022
  113. Rigon A, Infantino M, Merone M et al. (2017) The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: a multicenter evaluation and a review of the literature. Autoimmun Rev 16:1224–1229. https://doi.org/10.1016/j.autrev.2017.10.006
  114. Rigopoulou EI, Davies ET, Pares A et al. (2005) Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 54:528–532. https://doi.org/10.1136/gut.2003.036558
  115. Robier C, Amouzadeh-Ghadikolai O, Stettin M et al. (2015) Comparison of the clinical utility of the Elia CTD Screen to indirect immunofluorescence on Hep-2 cells. Clin Chem Lab Med 54:1365–1370. https://doi.org/10.1515/cclm-2015-1051
  116. Rouquette AM, Desgruelles C, Laroche P (2003) Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Pathol 120:676–681. https://doi.org/10.1309/GJHK-0D24-YDDX-W0NF
  117. Saeki H, Mabuchi T, Asahina A et al. (2023) English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). J Dermatol 50:e41–e68. https://doi.org/10.1111/1346-8138.16691
  118. Saleh MA, Salem H, El Azizy H (2017) Autoantibodies other than anti-desmogleins in pemphigus vulgaris patients. Indian J Dermatol 62:47–51. https://doi.org/10.4103/0019-5154.198032
  119. Satoh M, Chan EK, Ho LA et al. (2012) Prevalence and sociode-mographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 64:2319–2327. https://doi.org/10.1002/art.34380
  120. Satoh M, Tanaka S, Chan EK (2015) The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases. Front Immunol 6:181. https://doi.org/10.3389/fimmu.2015.0018
  121. Scholz J, Grossmann K, Knütter I et al. (2015) Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing. Clin Chem Lab Med 53:1991–2002. https://doi.org/10.1515/cclm-2015-0083
  122. Şener AG, Aydın N, Ceylan C et al. (2018) Investigation of antinuclear antibodies in chronic hepatitis B patients. Mikrobiyol Bul 52:425–430. https://doi.org/10.5578/mb.67262
  123. Sezin T, Vorobyev A, Sadik CD et al. (2018) Gene expression analysis reveals novel shared gene signatures and candidate molecular mechanisms between pemphigus and systemic lupus erythematosus in CD4+ T cells. Front Immunol 8:1992. https://doi.org/10.3389/fimmu.2017.01992
  124. Shah K, Maghsoudlou P (2016) Enzyme-linked immunosorbent assay (ELISA): the basics. Br J Hosp Med 77:C98–C101. https://doi.org/10.12968/hmed.2016.77.7.C98
  125. Shen C-Y, Hsieh S-C, Yu C-L et al. (2013) Autoantibody prevalence in active tuberculosis: reactive or pathognomonic? BMJ Open 3:e002665. https://doi.org/10.1136/bmjopen-2013-002665
  126. Shovman O, Gilburd B, Zandman-Goddard G et al. (2005) Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity 38:105–109. https://doi.org/10.1080/0891693040002270
  127. Singal AK, Bataller R, Ahn J et al. (2018) ACG clinical guideline: alcoholic liver disease. Am J Gastroenterol 113:175–194. https://doi.org/10.1038/ajg.2017.469
  128. Singh S, Singh U, Singh S (2010) Prevalence of autoantibodies in patients of psoriasis. J Clin Lab Anal 24:44–48. https://doi.org/10.1002/jcla.20365
  129. Soda P, Onofri L, Iannello G (2011) A decision support system for Crithidia luciliae image classification. Artif Intell Med 51:67–74. https://doi.org/10.1016/j.artmed.2010.05.005
  130. Solimani F, Forchhammer S, Schloegl A et al. (2021) Lichen planus—a clinical guide. J Dtsch Dermatol Ges 19:864–882. https://doi.org/10.1111/ddg.14565
  131. Solomon DH, Kavanaugh AJ, Schur PH et al. (2002) Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 47:434–444. https://doi.org/10.1002/art.10561
  132. Sternsdorf T, Guldner HH, Szostecki C et al. (1995) Two nuclear dot-associated proteins, PML and SplOO, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol 42:257–268. https://doi.org/10.1111/j.1365-3083.1995.tb03652.x
  133. Strachan DP (1989) Hay fever, hygiene, and household size. BMJ 299:1259–1260. https://doi.org/10.1136/bmj.299.6710.1259
  134. Sun Q, Wang L, Zhu HY et al. (2019) Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with chronic lymphocytic leukemia. Chin Med J 132:525–533. https://doi.org/10.1097/CM9.0000000000000114
  135. Swana G, Kariyawasam D, Carroll P et al. (2019) Practical aspects of introduction of multiplex bead technology into the routine diagnostic immunology laboratory. Clin Lab 65. https://doi.org/10.7754/Clin.Lab.2019.190147
  136. Tabatabaei MS, Ahmed M (2022) Enzyme-linked immunosorbent assay (ELISA). Methods Mol Biol 2508:115–134. https://doi.org/10.1007/978-1-0716-2376-3_10
  137. Tektonidou MG (2004) Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheumatol Dis 63:1159–1161. https://doi.org/10.1136/ard.2004.022624
  138. Tiede I, Fritz G, Strand S et al. (2003) CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 111:1133–1145. https://doi.org/10.1172/JCI16432
  139. Tiplady CW, Hamilton PJ, Galloway MJ (2000) Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine. Clin Lab Haematol 22:163–165. https://doi.org/10.1046/j.1365-2257.2000.00308.x
  140. Torok KS, Arkachaisri T (2010) Autoimmune thyroiditis in antinuclear antibody positive children without rheumatologic disease. Pediatr Rheumatol Online J 8:15. https://doi.org/10.1186/1546-0096-8-15
  141. Trépo C, Chan HLY, Lok A (2014) Hepatitis B virus infection. Lancet 384:2053–2063. https://doi.org/10.1016/S0140-6736(14)60220-8
  142. Vaglio A, Grayson PC, Fenaroli P et al. (2018) Drug-induced lupus: traditional and new concepts. Autoimmun Rev 17:912–918. https://doi.org/10.1016/j.autrev.2018.03.016
  143. van Zuuren EJ, Arents BWM, van der Linden MMD et al. (2021) Rosacea: new concepts in classification and treatment. Am J Clin Dermatol 22:457–465. https://doi.org/10.1007/s40257-021-00595-7
  144. Vavricka SR, Schoepfer A, Scharl M et al. (2015) Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 21:1982–1992. https://doi.org/10.1097/MIB.0000000000000392
  145. Vergani D, Bogdanos D-P (2003) Positive markers in AMA-negative PBC. Am J Gastroenterol 98:241–243. https://doi.org/10.1111/j.1572-0241.2003.07270.x
  146. Vignali DAA (2000) Multiplexed particle-based flow cytometric assays. J Immunol Methods 243:243–255. https://doi.org/10.1016/S0022-1759(00)00238-6
  147. Walker JG, Doniach D, Roitt IM et al. (1965) Serological tests in diagnosis of primary biliary cirrhosis. Lancet 285:827–831. https://doi.org/10.1016/S0140-6736(65)91372-3
  148. Wang R, Zhao H, Liu Y et al. (2021) Antinuclear antibodies with a nucleolar pattern are associated with a significant reduction in the overall survival of patients with leukemia: a retrospective cohort study. Front Oncol 11:631038. https://doi.org/10.3389/fonc.2021.631038
  149. Wang X, Fu Q, Song R et al. (2018) Antinuclear antibodies and interleukin responses in patients with Schistosoma japonicum infection. Parasite Immunol 40:e12577. https://doi.org/10.1111/pim.12577
  150. Watt FE, James OFW, Jones DEJ (2004) Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 97:397–406. https://doi.org/10.1093/qjmed/hch078
  151. Wesierska-Gadek J, Hohenuer H, Hitchman E et al. (1996) Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 110:840–847. https://doi.org/10.1053/gast.1996.v110.pm8608894
  152. Win T, Groves AM, Philliops GD (2003) Antinuclear antibody positive pleural effusion in a patient with tuberculosis. Respirology 8:396–397. https://doi.org/10.1046/j.1440-1843.2003.00472.x
  153. Woodland DL (2014) Hepatitis B infection: molecular mechanisms and pathogenesis. Viral Immunol 27:319–320. https://doi.org/10.1089/vim.2014.1504
  154. Worman HJ, Courvalin JC (2003) Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev 2:211–217. https://doi.org/10.1016/s1568-9972(03)00013-2
  155. Woźniacka A, Salamon M, McCauliffe D et al. (2013) Antinuclear antibodies in rosacea patients. Postepy Dermatol Alergol 30:1–5. https://doi.org/10.5114/pdia.2013.33372
  156. Yang Y, Krishna K, Deshpande P et al. (2018) High frequency of extractable nuclear autoantibodies in wheat-related disorders. Biomark Insights 13:1177271918782893. https://doi.org/10.1177/1177271918782893
  157. Yazdi F, Shakibi MR, Mirkamali H et al. (2021) Addison's disease in antiphospholipid syndrome: a rare complication. Clin Case Rep 9:e04107. https://doi.org/10.1002/ccr3.4107
  158. Zalla MJ, Muller SA (1996) The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders. Acta Dermato-Venereologica Suppl (Stockh) 195:1–15. PMID: 8721520.
  159. Zandman-Goddard G, Shoenfeld Y (2009) Parasitic infection and autoimmunity. Lupus 18:1144–1148. https://doi.org/10.1177/0961203309345735
Language: English
Submitted on: Jun 1, 2024
Accepted on: Nov 4, 2024
Published on: Jan 19, 2025
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Nikita Niranjan Kumar, Samir Ahmad Dit Al Hakim, Bogna Grygiel-Górniak, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.